Balanced news tone
News Sentiment
ABTT34 sentiment intelligence
Abbott Laboratories news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
53
Balanced news tone
20 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-3.4% over one week, +9.4% over four weeks, trend inactive, and near fair-value range.
Why Abbott stock is having its best day in 24 years
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
-3.4%
Price reacting lower
Trend fit
Trend inactive
9.4% over four weeks
Fair value
-19.7%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
4
Neutral
15
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
MSN
Direct company coverage
Why Abbott stock is having its best day in 24 years
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 18:47
- Source
- MSN
Proactive financial news
Direct company coverage
Market movers: AtaiBeckley, UnitedHealth Group, Abbott Laboratories, Medicus Pharma…
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 14:30
- Source
- Proactive financial news
Proactive financial news
Direct company coverage
Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 16 Jul 2026 12:23
- Source
- Proactive financial news
PR Newswire
Direct company coverage
Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 16 Jul 2026 11:30
- Source
- PR Newswire
GuruFocus
Direct company coverage
Abbott Laboratories (ABT) Shares Fall 3.4% -- What GF Score of 7
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 14 Jul 2026 21:39
- Source
- GuruFocus
TechStock²
Direct company coverage
Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jul 2026 21:01
- Source
- TechStock²
TradingView
Direct company coverage
How Are Emerging Markets Supporting Abbott's EPD Momentum?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- TradingView
GuruFocus
Direct company coverage
Is It Too Late to Buy Abbott Laboratories (ABT) After 4.4% Rally? GF Value Says Undervalued
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- GuruFocus
Barchart.com
Direct company coverage
Abbott Laboratories Stock Is Getting Decimated, But the Smart Money Senses Opportunity
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Barchart.com
IndexBox
Direct company coverage
Abbott Laboratories, Coca-Cola, and Walmart: Top Recession-Proof Stocks for 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- IndexBox
Barchart.com
Direct company coverage
Abbott Stock Is Trading at 52-Week Lows but Insiders Are Gobbling Up Shares of This Blue-Chip Dividend Payer
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 05 May 2026 07:00
- Source
- Barchart.com
GuruFocus
Direct company coverage
ABT: Abbott Laboratories Director Acquires 10,000 Shares Amid De
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- GuruFocus
Seeking Alpha
Direct company coverage
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
Barchart.com
Direct company coverage
Abbott Stock Crash: Rebound Could Be Coming Fast
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Apr 2026 07:00
- Source
- Barchart.com
GuruFocus
Direct company coverage
Abbott Laboratories (ABT) Set for Q1 Earnings Report with Modest Growth Expectations
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 15 Apr 2026 07:00
- Source
- GuruFocus
IndexBox
Direct company coverage
Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences Acquisition - News and Statistics
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Mar 2026 07:00
- Source
- IndexBox
Market source
Direct company coverage
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
PR Newswire
Direct company coverage
Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Jan 2026 08:00
- Source
- PR Newswire
WSJ
Direct company coverage
Abbott to Acquire Exact Sciences for $21 Billion
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Nov 2025 08:00
- Source
- WSJ
WSJ
Direct company coverage
Abbott Laboratories Gets Boost From U.S. Covid-19 Testing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2020 07:00
- Source
- WSJ